
PBI-4050
PBI-4050
Catalog No. M10026
PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively.
Size | Price / USD | Stock | Quantity |
2MG | 61 | Get Quote |
![]() ![]() |
5MG | 87 | Get Quote |
![]() ![]() |
10MG | 129 | Get Quote |
![]() ![]() |
25MG | 232 | Get Quote |
![]() ![]() |
50MG | 332 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePBI-4050
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Gagnon L, et al. Am J Pathol. 2018 May;188(5):1132-1148. 2. Li Y, et al. JCI Insight. 2018 May 17;3(10). pii: 120365.
molnova catalog



related products
-
Fasiglifam
A potent, selective, orally bioavailable GPR40 (FFA1) agonist with EC50 of 14 nM.
-
LY2922470
LY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM; displays no activity against PPARα/β/γ (>10 uM).
-
PBI-4050 sodium
PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively.